#news #biotech After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B .After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B
badams
Mon, 03/29/2021 – 10:09

from FierceBiotech: Biotech https://ift.tt/3sCXDFo